Abstract
A UK-wide database of structured asthma review consultations was used to investigate the prevalence of ‘off-label’ anti-asthma prescriptions in relationship to clinical symptoms of asthma control. The 1050 children (6.1%) aged 16 years or under issued with an off-label prescription reported more nighttime, daytime and activity asthma symptoms, and used more short-acting ß2-agonist medication than their peers. Off-label prescribing for children with asthma in UK primary care is associated with worse levels of self-reported asthma control.
Original language | English |
---|---|
Pages (from-to) | 220-222 |
Number of pages | 3 |
Journal | British Journal of General Practice |
Volume | 57 |
Issue number | 536 |
Publication status | Published - Mar 2007 |
Keywords
- Asthma
- Child health
- Drug labeling
- Family practice
- Prescriptions